Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M.

Drug Des Devel Ther. 2018 Apr 30;12:1033-1044. doi: 10.2147/DDDT.S145545. eCollection 2018. Review.

2.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Jat KR, Walia DK, Khairwa A.

Cochrane Database Syst Rev. 2018 Mar 18;3:CD010288. doi: 10.1002/14651858.CD010288.pub4. Review.

PMID:
29551015
3.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767
4.

Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis.

Yao Y, Zhou H, Shen Y, Yang Q, Ye J, Lu G, Fu Y, Lou H, Yu Y, Zhou J.

Medicine (Baltimore). 2017 Dec;96(51):e9436. doi: 10.1097/MD.0000000000009436.

5.

Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study.

Ji Y, Song Y, Zhou F, Liu T, Jiang M, Zhao X, Huang X.

Medicine (Baltimore). 2017 Dec;96(52):e9443. doi: 10.1097/MD.0000000000009443.

6.

Difficult to treat osteoarticulars infections : Focus on Mycobacterial and Fungal infection.

Yombi JC, Seyler L, Cornu O, Barbier O, Libouton X, Rodriguez-Villalobos H, Thienpont E.

Acta Orthop Belg. 2017 Mar;83(1):110-123. Review.

PMID:
29322903
7.

Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.

Cho SY, Lee DG, Choi JK, Lee HJ, Kim SH, Park SH, Choi SM, Choi JH, Yoo JH, Park YJ, Lee JW.

Medicine (Baltimore). 2017 Dec;96(49):e8841. doi: 10.1097/MD.0000000000008841.

8.

Metal-homeostasis in the pathobiology of the opportunistic human fungal pathogen Aspergillus fumigatus.

Blatzer M, Latgé JP.

Curr Opin Microbiol. 2017 Dec;40:152-159. doi: 10.1016/j.mib.2017.11.015. Epub 2017 Nov 24. Review.

PMID:
29179120
9.

A Review of Onychomycosis Due to Aspergillus Species.

Bongomin F, Batac CR, Richardson MD, Denning DW.

Mycopathologia. 2018 Jun;183(3):485-493. doi: 10.1007/s11046-017-0222-9. Epub 2017 Nov 16. Review.

10.

Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.

Hou X, Zhang H, Kou L, Lv W, Lu J, Li J.

Medicine (Baltimore). 2017 Oct;96(42):e8315. doi: 10.1097/MD.0000000000008315.

Supplemental Content

Loading ...
Support Center